Dr. Alberto A Chiappori, MD
Claim this profileMoffitt Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
23 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
PD-L1 negative
2Non-Small Cell Lung Cancer
Stage IV
PD-L1 negative
PD-L1 positive
Affiliated Hospitals
Clinical Trials Alberto A Chiappori, MD is currently running
CAR T-Cell Therapy
for Small Cell Lung Cancer
This trial tests specially modified immune cells in patients with advanced lung cancers. These immune cells are designed to find and destroy cancer cells by targeting a specific protein on them.
Recruiting1 award Phase 112 criteria
IPH5201 + Durvalumab + Chemotherapy
for Lung Cancer
The study is intended to assess the safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab in untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC).
Recruiting1 award Phase 211 criteria
More about Alberto A Chiappori, MD
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Alberto A Chiappori, MD has experience with
- Nivolumab
- Ipilimumab
- Durvalumab
- Pembrolizumab
- Bemcentinib
- Erlotinib
Breakdown of trials Alberto A Chiappori, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Malignant Pleural Mesothelioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alberto A Chiappori, MD specialize in?
Alberto A Chiappori, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Alberto A Chiappori, MD currently recruiting for clinical trials?
Yes, Alberto A Chiappori, MD is currently recruiting for 3 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Alberto A Chiappori, MD has studied deeply?
Yes, Alberto A Chiappori, MD has studied treatments such as Nivolumab, Ipilimumab, Durvalumab.
What is the best way to schedule an appointment with Alberto A Chiappori, MD?
Apply for one of the trials that Alberto A Chiappori, MD is conducting.
What is the office address of Alberto A Chiappori, MD?
The office of Alberto A Chiappori, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.